Pharmaceutical Business review

Synutra infant formula receives Chinese approval

The safety of the products has been confirmed by Government of Duchang County in Jiangxi Province, China.

Incidents of a male infant death and illness of his twin sister in Jiangxi Province, led to the tests which revealed that food was not the reason behind the same.

Synutra CEO Liang Zhang said the government’s prompt reaction and confirmation of the safety of its infant formula products would relax the concerns of its consumers.

"As the government testing results reinforce, Synutra is a company dedicated to producing safe and high quality products to better safeguard the health and nutrition of infants in China," Zhang added.